$SoFi Technologies(SOFI.US)$
sofi market sentiment 👀

Nine of 15 technical indicators tracked by moomoo are showing no obvious signal for $GameStop(GME.US)$, even after the stock closed more than 20% higher Monday.
Four technical indicators are negative, including OSC oscillator, which measures the difference between the current price and the average price over some time. That indicator, shown below, is signaling the stock is severely overbought and the trend is bearish.
In the options market, more tha...

$NVIDIA(NVDA.US)$ shares almost tripled in the past year as the AI-favorite kept delivering quarterly financial results that blew past estimates. Is it now due for a pullback?
Eleven of the technical indicators signal the stock is overbought and the trend could be turning bearish.
Nvidia is holding on to its second place among the most-heavily trade stock options, just closely behind $Tesla(TSLA.US)$.
Disclaimer:This p...

Recently, $GameStop(GME.US)$ stock price explosively surged, with after-hours trading astonishingly soaring by 80%!
Click to enter the GME Options Chain
Missed the background? Don't worry, I've got you covered.
Here's what happened.
Behind all this excitement is a name you should know—Roaring Kitty.
Who is it? He was a pivotal figure in the GameStop saga of 2021, rallying day traders to challenge short-sellers and...

Will $Lucid Group(LCID.US)$ stock reach $10 in 2024?

$Novavax(NVAX.US)$ tonight just watch show only

$Novavax(NVAX.US)$
In 2024, Novavax's development reached a new climax, and the company's stock price and business development showed impressive performance. From a $1.2 billion vaccine license agreement with Sanofi to plans to promote its JN.1 protein-based non-mRNA COVID-19 vaccine globally, Novavax has certainly taken a place in the global biotech industry. In this context, many investors may be asking: is Novavax's stock still worth buying at the current price of $8-10?
Strong market dynamics
Novavax not only soared more than 99% in the first quarter of 2024, but also announced strong financial results. All of this further strengthened the market's confidence in its business model after the company reached a major vaccine licensing agreement with Sanofi. This type of collaboration provides a continuous revenue stream, while also showing Novavax's competitiveness and brand influence in the global vaccine market.
Innovative vaccine development
Additionally, the World Health Organization (WHO) recommended Novavax's JN.1 COVID-19 vaccine, which not only recognized its technology and product effectiveness, but also opened the door to the upcoming fall vaccine market. According to the company's latest non-clinical data, JN...

$SoFi Technologies(SOFI.US)$ BULLSSSSSS

$SoFi Technologies(SOFI.US)$ LOLLL